Patents by Inventor Stephen Wesley Leonard

Stephen Wesley Leonard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11866762
    Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: January 9, 2024
    Assignee: QVELLA CORPORATION
    Inventors: Samad Talebpour, Aye Aye Khine, Tino Alavie, Stephen Wesley Leonard
  • Publication number: 20230235274
    Abstract: Systems and methods are provided for classifying microbial cells according to morphological features of microcolonies. A dark-field objective is employed to acquire a dark-field image of a microcolony during a microcolony growth phase that is characterized by phenotypic expression of microcolony morphological features which evolve with time and are differentiated among classes of microbial cell types. The dark-field image is processed to classify the microcolony according to two or more microbial cell types, such as Gram status and/or speciation. The dark-field objective may have a numerical aperture selected to facilitate the imaging of microcolony morphological features, residing, for example, between 0.15 and 0.35. A set of dark-field images of a microcolony may be collected during the microcolony growth phase and processed to classify the microcolony. Classification may be performed according to a temporal ordering of the dark-field images, for example, using a recurrent neural network.
    Type: Application
    Filed: June 25, 2021
    Publication date: July 27, 2023
    Inventors: Samad TALEBPOUR, Anna KHIMCHENKO, Maryam ASADISHEKARI, Stephen Wesley LEONARD
  • Publication number: 20220042066
    Abstract: An integrated fluidic device is employed to perform microbial cell separation, in situ microcolony growth, and optional identification and antimicrobial susceptibility testing. While the integrated fluidic device is maintained in a closed state, microbial cell separation is performed to provide a microbial cell suspension that is contacted with a solid phase growth medium. A liquid component of the suspension is removed, thereby retaining microbial cells on the growth medium for incubation, growth, and subsequent harvesting and characterization. In some embodiments, antimicrobial susceptibility testing is performed by contacting growth media with a solid support having an antimicrobial agent provided thereon, such that the antimicrobial agent diffuses into a subregion of the growth medium that is accessible through an aperture surrounded, at least in part, by the solid support.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 10, 2022
    Inventors: SAMAD TALEBPOUR, ROBERT MAASKANT, AYE AYE KHINE, STEPHEN WESLEY LEONARD, VILCY PARMAR, ANNA KHIMCHENKO, MARYAM ASADISHEKARI, SUKHDEV MANKU, SANJESH YASOTHARAN, TINO ALAVIE, ALALEH SAMIEI
  • Publication number: 20210246483
    Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 12, 2021
    Inventors: Samad Talebpour, Aye Aye Khine, Tino Alavie, Stephen Wesley Leonard
  • Patent number: 10988794
    Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: April 27, 2021
    Assignee: QVELLA CORPORATION
    Inventors: Samad Talebpour, Aye Aye Khine, Tino Alavie, Stephen Wesley Leonard
  • Publication number: 20190177766
    Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production of m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
    Type: Application
    Filed: February 20, 2019
    Publication date: June 13, 2019
    Inventors: Samad Talebpour, Aye Aye Khine, Tino Alavie, Stephen Wesley Leonard
  • Patent number: 10233483
    Abstract: Methods are provided for performing antibiotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the presence of a selected antibiotic and a stimulus is provided to induce the production on m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: March 19, 2019
    Assignee: QVELLA CORPORATION
    Inventors: Samad Talebpour, Aye Aye Khine, Tino Alavie, Stephen Wesley Leonard
  • Publication number: 20160138072
    Abstract: Methods are provided for performing antibotic susceptibility testing based on the detection of RNA, such as tmRNA, from microbial cells after exposure to antibiotics. In some embodiments, aliquots are obtained from a sample, one of which contains a selected antibiotic. The aliquots, which include growth media, are incubated under conditions suitable for microbial growth, and the microbial cells in each aliquot are removed and lysed, and the lysate is subjected to reverse transcription and amplification in infer the effect of the selected antibiotic on the microbial cells. In one embodiment, a sample containing microbial cells is incubated in the pressence of a selected antibiotic and a stimulus is provided to induce the production on m RNA within the microbial cells. The microbial cells are subsequently lysed without substantial degradation of the m RNA within the lysate, and the m RNA is detected to determine the effect of the antibiotic on the microbial cells.
    Type: Application
    Filed: July 3, 2014
    Publication date: May 19, 2016
    Inventors: Samad Talebpour, Aye Aye Khine, Tino Alavie, Stephen Wesley Leonard
  • Publication number: 20130176291
    Abstract: Devices and methods are provided for controlling a display of a portable display device based on input form a plurality of ambient light photosensors positioned proximal to edges of the display. The display device includes one or more orientation sensors configured such that processing circuitry of the display device may determine, based on input from the orientation sensors, an operative orientation of the device relative to gravity, and subsequently identify an uppermost display edge. Signals from the ambient light photosensors proximal to the uppermost display edge are employed to control the display.
    Type: Application
    Filed: January 3, 2013
    Publication date: July 11, 2013
    Inventor: Stephen Wesley Leonard